Pharmacological and environmental interventions in the control of myopia: a review of scientific literature
DOI:
https://doi.org/10.33936/qkrcs.v6i2.4669Keywords:
miopía, hábitos, atropina, farmacología, eficaciaAbstract
Within the areas of visual health, myopia is recognized as a public health problem, being a risk factor for serious eye conditions such as retinal tears, breaks or detachments or keratoconus. The purpose of managing myopia is to limit its progression, using ophthalmic correction with glasses and contact lenses, orthokeratology, pharmacological management and behavioral changes in outdoor visual habits. In any of the intervention methods, a decrease in changes in axial length and a decrease in dioptric progression of patients compared to untreated myopic patients is observed. This has been demonstrated by public scientific meta-analyses taken as reference with the purpose of showing the theoretical advances and unifying knowledge focused on clinical practice. It is recognized that the most effective interventions have been pharmacological, also presenting a limitation in the risk of developing pathological myopia in a three-year treatment regimen and taking into account behavioral changes in myopic patients, such as outdoor activities as prophylactic treatment.
Downloads
References
Organización Mundial de la Salud. Informe mundial sobre la visión [Internet]. 2020. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/331423/9789240000346-spa.pdf
Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. Ophthalmology [Internet] 2016;123:1036-42. Disponible en: https://doi.org/10.1016/J.OPHTHA.2016.01.006
Jong M, Flitcroft Di. IMI Defining and Classifying Myopia Report. International Myopia Institute [Internet]. 2019. Disponible en: https://myopiainstitute.org/wp-content/uploads/2020/09/IMI-Defining-and-Classifying-Myopia-Report_FINALv2-1.pdf
Chamberlain P, Lazon de la Jara P, Arumugam B, Bullimore MA. Axial length targets for myopia control. Ophthalmic and Physiological Optics [Internet]. 2021;41:523-31. Disponible en: https://doi.org/10.1111/OPO.12812
Milán-Castillo R, Domínguez-Dueñas F, Molina-Lespron A. Frecuencia de miopía en adultos de la Ciudad de México: resultados de una campaña de salud visual. Rev Mex Oftalmol [Internet]. 2012;95(5):203-208. Disponible en: https://doi.org/10.24875/rmo.m21000185
Velázquez R. Miopía II. Optometría. Revista Imagen Óptica [Internet]. 2020;22:44-48. Disponible en: https://issuu.com/imagenoptica/docs/may-jun_2020/s/10844059
Tedja MS, Haarman AEG, Meester-Smoor MA, Kaprio J, Mackey DA, Guggenheim JA, et al. IMI – Myopia genetics report. Investigative Ophthalmology and Visual Science [Internet]. 2019;60:89-105. Disponible en: https://doi.org/10.1167/iovs.18-25965
Brien Holden Vision Institute Foundation. What Is Myopia? | BHVI [Internet]. Disponible en: https://bhvi.org/myopia-calculator-resources/myopia-awareness-week/what-is-myopia/ [consultada 2022.04.13].
International Myopia Institute. Myopia [Internet]. Disponible en: https://myopiainstitute.org/myopia/# [consultada 2022.04.26].
Pedrajas MT. Revisión de la literatura sobre las modalidades para el control de la progresión de la miopía [Internet]. Disponible en: https://upcommons.upc.edu/bitstream/handle/2117/356277/TFG_Maria_Teresa_Pedrajas.pdf?sequence=2&isAllowed=y Universitat Politècnica de Catalunya, 2021 [consultada 2021.08.20].
Cos Leon J. Eficacia de los diferentes métodos utilizados para el control de la miopía. Evidencia científica [Internet]. Disponible en: https://upcommons.upc.edu/bitstream/handle/2117/192409/jordi.cos%20-%20TFG%20JORDI%20definitivo%20%20%281%29_0%20Obert.pdf?sequence=3&isAllowed=y Universitat Politècnica de Catalunya, 2019 [consultada 2021.08.20].
Aguilar GG. Criterios clínicos para la corrección de la miopía [Internet]. Disponible en: https://upcommons.upc.edu/bitstream/handle/2117/190918/guillerma.galicia%20-%20TFG%20GUILLERMA%20GALICIA%20obert.pdf?sequence=3&isAllowed=y Universitat Politècnica de Catalunya, 2019 [consultada 2021.08.20].
Wildsoet CF, Chia A, Cho P, Guggenheim JA, Polling JR, Read S, et al. IMI – Interventions myopia institute: Interventions for controlling myopia onset and progression report. Investigative Ophthalmology and Visual Science [Internet]. 2019;60:106-131. Disponible en: https://doi.org/10.1167/iovs.18-25958
Porter D. Control de la miopía en los niños. American Academy of Ophthalmology [Internet]. Disponible en: https://www.aao.org/salud-ocular/tratamientos/control-de-la-miop%C3%ADa-en-los-ni%C3%B1os [consultada 2021.08.20].
Polling JR, Tan E, Driessen S, Loudon SE, Wong HL, van der Schans A, et al. A 3-year follow-up study of atropine treatment for progressive myopia in Europeans. Eye (Basingstoke) [Internet]. 2020;34:2020-8. Disponible en: https://doi.org/10.1038/S41433-020-1122-7
Philip K. What’s New in Spectacle Lenses for Myopia Management? | BHVI. Myopia in Focus, Review of Myopia Management 2021 [Internet]. 2021. Disponible en: https://bhvi.org/news/whats-new-in-spectacle-lenses-for-myopia-management/ [consultada 2022.04.30].
Yan Shun Weng, R. Cycloplegic Refraction in Managing Myopia | BHVI. Global Myopia Centre, Myopia in Focus [Internet]. 2020. Disponible en: https://bhvi.org/news/cycloplegic-refraction-in-managing-myopia/ [consultada 2022.04.30].
Lanca C, Teo A, Vivagandan A, Htoon HM, Najjar RP, Spiegel DP, Pu SH, Saw SM. The effects of different outdoor environments, sunglasses and hats on light levels: Implications for myopia prevention. Translational Vision Science and Technology [Internet]. 2019;8(4). Disponible en: https://doi.org/10.1167/TVST.8.4.7
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Zulma Samara Santos Rueda, Danna Isabella García Salas

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.